IA
DFTX

IFP Advisors’s Definium Therapeutics DFTX Stock Holding History

IFP Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-984
Closed -$6.47K – 3726
2025
Q1 		$5.94K Buy
+984
New +$7.05K ﹤0.01% 2768
2024
Q4 		– Sell
-1,000
Closed -$6.88K – 3994
2024
Q3 		$5.69K Sell
1,000
-1,000
-50% -$6.96K ﹤0.01% 2622
2024
Q2 		$14.4K Buy
2,000
+1,970
+6,567% +$17.2K ﹤0.01% 2205
2024
Q1 		$282 Hold
30
– – ﹤0.01% 3015
2023
Q4 		$110 Hold
30
– – ﹤0.01% 2969
2023
Q3 		$94 Hold
30
– – ﹤0.01% 3220
2023
Q2 		$107 Hold
30
– – ﹤0.01% 3350
2023
Q1 		$360 Sell
30
-203
-87% -$675 ﹤0.01% 3225
2022
Q4 		$7K Sell
233
-15,261
-98% -$42.4K ﹤0.01% 3613
2022
Q3 		$13K Buy
15,494
+14,461
+1,400% +$139K ﹤0.01% 3455
2022
Q2 		$13K Hold
1,033
– – ﹤0.01% 3201
2022
Q1 		$13K Buy
1,033
+296
+40% +$5.13K ﹤0.01% 3201
2021
Q4 		$16K Sell
737
-100
-12% -$3.19K ﹤0.01% 2047
2021
Q3 		$29K Buy
837
+27
+3% +$1.17K ﹤0.01% 1819
2021
Q2 		$42K Buy
+810
New +$42.5K ﹤0.01% 1604

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IFP Advisors's DFTX Position: Q2 2025 in Review

IFP Advisors sold out of Definium Therapeutics (DFTX) in Q2 2025, closing a stake of 984 shares — an estimated $6.47K sold.

IFP Advisors first reported a position in DFTX in Q2 2021 and held it in 15 quarters. The position peaked at $42K in Q2 2021. 181 funds tracked by Wall St. Rank hold DFTX as of Q2 2025.

  • IFP Advisors reported no remaining Definium Therapeutics position as of Q2 2025 after selling out during the quarter.
  • IFP Advisors sold 984 Definium Therapeutics shares in Q2 2025, an estimated $6.47K.
  • IFP Advisors first reported a position in Definium Therapeutics in Q2 2021 and held it in 15 quarters.
  • IFP Advisors's Definium Therapeutics position peaked at $42K in Q2 2021.
  • 181 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.